The oncology residency is a specialized program consisting of 12 months of individualized training designed to provide diverse clinical experience which focuses on direct patient care, education and clinical research. The program combines traditional rotations and longitudinal learning experiences to develop an expert level knowledge base in our graduates. The resident will work with established pharmacy clinicians on interdisciplinary teams throughout Duke University Hospital and the Duke Comprehensive Cancer Center. Upon completion of this program, the resident will have the clinical skills and experience necessary to practice as an oncology clinical specialist in a variety of settings and will be prepared to attain board certification (BCOP).


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The purpose of the Postgraduate Year Two (PGY2) Oncology Pharmacy Residency Program is to prepare the resident to practice in the area of oncology as a clinical pharmacy specialist, as a clinical faculty member or to continue post graduate training (e.g., another residency or fellowship). Further, the resident will be prepared to take and pass the BCOP certification examination. Excellence will be achieved by:

  • Demonstrating accountability for patient care
  • Modeling excellence in oncology pharmaceutical care
  • Serving as professional role models for pharmacy students and PGY1 residents
  • Participating in clinical research and performance improvement projects focused on oncology pharmacotherapy
  • Facilitating, leading, and actively participating in oncology pharmacotherapy discussion in the Oncology Discussion Series


Required Outcomes

  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with cancer.
  • Optimize the outcomes of the care of individuals with cancer by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
  • Manage and improve the medication-use process in oncology patient care areas.
  • Demonstrate excellence in the provision of training or educational activities for health care professionals and health care professionals in training.
  • Promote health improvement, wellness, and cancer prevention.
  • Sustain the ongoing development of expertise and professionalism in the practice of oncology pharmacy.
  • Conduct oncology pharmacy practice research.
  • Function effectively in oncology settings participating in clinical investigations.

Elective Outcomes

  • Publish cancer-related topics.

Program Graduation Requirements

In order to receive his/her residency certificate, the resident must complete all requirements outlined by the Residency Graduation and Completion policy. 

Resources for Applicants